Fmr LLC Ani Pharmaceuticals Inc Transaction History

Fmr LLC

$1.49 Trillion
Q1 2025

A detailed history of Fmr LLC transactions in Ani Pharmaceuticals Inc stock. As of the latest transaction made, Fmr LLC holds 3,576 shares of ANIP stock, worth $221,390. This represents 0.0% of its overall portfolio holdings.

Number of Shares

3,576

Previous 3,091 15.69%

Holding current value

$221,390

Previous $170,000 40.59%

% of portfolio

0.0%

Previous 0.0%

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 12, 2025	BUY	$53.93 - $68.36 $26,156 - $33,154	485 Added 15.69%	3,576 $239,000
Q4 2024 Feb 13, 2025	SELL	$53.35 - $61.74 $816,788 - $945,239	-15,310 Reduced 83.2%	3,091 $170,000
Q3 2024 Nov 13, 2024	BUY	$54.33 - $65.72 $215,798 - $261,039	3,972 Added 27.53%	18,401 $1.1 Million
Q2 2024 Aug 13, 2024	BUY	$58.53 - $68.82 $812,689 - $955,565	13,885 Added 2552.39%	14,429 $918,000
Q1 2024 May 13, 2024	BUY	$54.2 - $69.69 $2,710 - $3,484	50 Added 10.12%	544 $37,000
Q4 2023 Feb 13, 2024	BUY	$48.72 - $65.43 $146 - $196	3 Added 0.61%	494 $27,000
Q3 2023 Nov 13, 2023	BUY	$50.28 - $64.61 $1,759 - $2,261	35 Added 7.68%	491 $28,000
Q2 2023 Aug 11, 2023	BUY	$37.29 - $53.83 $6,003 - $8,666	161 Added 54.58%	456 $24,000
Q1 2023 May 11, 2023	BUY	$37.61 - $45.72 $488 - $594	13 Added 4.61%	295 $11,000
Q4 2022 Feb 13, 2023	SELL	$31.9 - $41.95 $2,296 - $3,020	-72 Reduced 20.34%	282 $11,000
Q3 2022 Nov 10, 2022	BUY	$29.83 - $38.01 $7,934 - $10,110	266 Added 302.27%	354 $11,000
Q2 2022 Aug 12, 2022	SELL	$23.09 - $33.46 $1,131 - $1,639	-49 Reduced 35.77%	88 $2,000
Q1 2022 May 13, 2022	BUY	$26.91 - $47.15 $3,686 - $6,459	137 New	137 $4,000
Q3 2021 Nov 15, 2021	SELL	$26.48 - $35.99 $317 - $431	-12 Closed	0 $0
Q2 2021 Aug 13, 2021	BUY	$31.86 - $38.6 $382 - $463	12 New	12 $0

Others Institutions Holding ANIP

# of Institutions

239

Shares Held

20.2M

Call Options Held

7.4K

Put Options Held

12.4K

View Full List

About ANI PHARMACEUTICALS INC

Ticker ANIP
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 17,426,000
Market Cap $1.08B
Description
ANI Pharmaceuticals, Inc., a biopharmaceutical company, develops, manufactures, and markets branded and generic prescription pharmaceuticals in the United States and Canada. It focuses on producing controlled substances, oncology products, hormones and steroids, injectables, and other formulations. The company manufactures oral solid dose produc...

More about ANIP

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Fmr LLC, based on Form 13F filings with the SEC.

News

Stay updated on Fmr LLC with notifications on news.

Account